Breaking News Instant updates and real-time market news.

TTPH

Tetraphase

$0.26

-0.0046 (-1.77%)

07:12
09/03/19
09/03
07:12
09/03/19
07:12

Tetraphase downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright analyst Ed Arce downgraded Tetraphase Pharmaceuticals to Neutral from Buy without a price target. The company's $30.7M debt repayment, disclosed on Friday night, "may represent an ominous signal," Arce tells investors in a research note. The analyst says he does not know why the loan was repaid in full so early. Plus, given the difficult environment currently for antibiotics companies to access the capital markets at reasonable terms, the overall risk profile of Tetraphase "has now risen considerably," contends the analyst.

  • 09

    Sep

  • 25

    Sep

TTPH Tetraphase
$0.26

-0.0046 (-1.77%)

01/04/19
RILY
01/04/19
INITIATION
Target $3
RILY
Buy
Tetraphase resumed with a Buy at B. Riley FBR
B. Riley FBR analyst David Buck resumed coverage of Tetraphase Pharmaceuticals with a Buy rating and $3 price target.
03/15/19
PIPR
03/15/19
NO CHANGE
Target $4
PIPR
Overweight
Tetraphase price target lowered to $4 from $6 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Tetraphase Pharmaceuticals to $4 from $6 after the launch of Xerava came in below his estimates. The analyst now forecast Xerava sales of $3.5M in 2019 and $10.5M in 2020. Further, Tetraphase will delay Xerava launch in Europe to focus on U.S. launch, the analyst tells investors in a post-earnings research note. He reiterates an Overweight rating on the shares.
03/16/19
GABE
03/16/19
DOWNGRADE
GABE
Hold
Tetraphase downgraded to Hold from Buy at Gabelli
05/10/19
RHCO
05/10/19
NO CHANGE
Target $4
RHCO
Buy
Tetraphase price target lowered to $4 from $10 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Tetraphase to $4 after its lower than expected Q1 revenue but keeps his Buy rating on the "meaningful progress" being made with its Xerava launch. The analyst contends that the antibiotic hospital launches take some time and "patience is required" before Xerava starts to see a "meaningful" pull-through in Q4 of this year or in Q1 of FY20. The analyst adds that he reduced his assumed penetration for Xerava to a more "tempered" uptake that is "typical" in hospital settings.

TODAY'S FREE FLY STORIES

SVRA

Savara

$2.49

-0.14 (-5.32%)

16:20
09/18/19
09/18
16:20
09/18/19
16:20
Hot Stocks
Savara to present additional Molgradex data at ERS »

Savara announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
09/18/19
09/18
16:20
09/18/19
16:20
Options
Closing CBOE SPX and VIX Index summary for September 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:20
09/18/19
09/18
16:20
09/18/19
16:20
General news
More division on the FOMC amid myriad uncertainties »

More division on the FOMC…

BA

Boeing

$386.31

1.7 (0.44%)

16:17
09/18/19
09/18
16:17
09/18/19
16:17
Periodicals
FAA head says won't unground 737 MAX until he flies it himself, CNBC says »

Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

TNDM

TNDM

16:17
09/18/19
09/18
16:17
09/18/19
16:17
Hot Stocks
Tandem Diabetes says published results of t:slim X2 pump show reduced events »

Tandem Diabetes announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
09/18/19
09/18
16:17
09/18/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCP

HCP

$34.94

-0.18 (-0.51%)

16:16
09/18/19
09/18
16:16
09/18/19
16:16
Hot Stocks
HCP announces $1B commercial paper note program »

HCP announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$18.22

0.09 (0.50%)

16:16
09/18/19
09/18
16:16
09/18/19
16:16
Hot Stocks
KeyCorp lowers prime lending rate to 5.00% »

KeyCorp and its banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

FBM

Foundation Building Materials

$18.92

0.03 (0.16%)

16:16
09/18/19
09/18
16:16
09/18/19
16:16
Syndicate
Foundation Building Materials files to sell 4.75M shares of common stock »

BofA Merrill Lynch and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
09/18/19
09/18
16:16
09/18/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAY

Dave & Buster's

$40.75

0.23 (0.57%)

16:15
09/18/19
09/18
16:15
09/18/19
16:15
Initiation
Dave & Buster's initiated  »

Dave & Buster's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRVB

Provention Bio

$9.67

0.3 (3.20%)

16:14
09/18/19
09/18
16:14
09/18/19
16:14
Syndicate
Provention Bio files to sell common stock, no amount given »

SVB Leerink and Cantor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

COST

Costco

$292.37

0.86 (0.30%)

16:13
09/18/19
09/18
16:13
09/18/19
16:13
Downgrade
Costco rating change  »

Costco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

SPFI

South Plains Financial

$16.53

(0.00%)

16:12
09/18/19
09/18
16:12
09/18/19
16:12
Hot Stocks
South Plains Financial Chief Credit Officer Kevin Bass resigns »

South Plains Financial,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MLHR

Herman Miller

$44.54

0.04 (0.09%)

16:12
09/18/19
09/18
16:12
09/18/19
16:12
Hot Stocks
Herman Miller up 5% to $46.80 after Q1 results beat estimates »

The midpoint of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Oct

  • 22

    Oct

MLHR

Herman Miller

$44.50

(0.00%)

16:11
09/18/19
09/18
16:11
09/18/19
16:11
Hot Stocks
Herman Miller CFO: We continue to navigate the global tariff picture effectively »

Jeff Stutz, CFO, noted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Oct

  • 22

    Oct

ETSY

Etsy

$59.47

-0.45 (-0.75%)

16:10
09/18/19
09/18
16:10
09/18/19
16:10
Syndicate
Breaking Syndicate news story on Etsy »

Etsy announces $650M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

MLHR

Herman Miller

$44.50

(0.00%)

16:09
09/18/19
09/18
16:09
09/18/19
16:09
Hot Stocks
Herman Miller CEO says 'executing at a very high level' »

Andi Owen, President and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Oct

  • 22

    Oct

MSFT

Microsoft

$138.48

1.08 (0.79%)

16:08
09/18/19
09/18
16:08
09/18/19
16:08
Hot Stocks
Microsoft announces new $40B share repurchase program, 11% dividend hike »

Microsoft announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AVNW

Aviat Networks

$14.20

0.1 (0.71%)

16:08
09/18/19
09/18
16:08
09/18/19
16:08
Hot Stocks
Aviat Networks CEO Michael Pangia resigns, interim CEO Stan Gallagher appointed »

Aviat Networks appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

$44.47

-0.03 (-0.07%)

16:07
09/18/19
09/18
16:07
09/18/19
16:07
Earnings
Herman Miller sees Q2 diluted EPS 85c-89c, consensus 85c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Oct

  • 22

    Oct

RH

RH

$171.11

-1.61 (-0.93%)

16:07
09/18/19
09/18
16:07
09/18/19
16:07
Earnings
RH raises FY19 guidance by 25c to $10.75-$11.01 after convertible debt offering »

Consensus $10.69. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DENN

Denny's

$22.61

0.08 (0.36%)

16:07
09/18/19
09/18
16:07
09/18/19
16:07
Initiation
Denny's initiated  »

Denny's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

WING

Wingstop

$86.89

0.93 (1.08%)

16:06
09/18/19
09/18
16:06
09/18/19
16:06
Initiation
Wingstop initiated  »

Wingstop initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MLHR

Herman Miller

$44.47

-0.03 (-0.07%)

16:06
09/18/19
09/18
16:06
09/18/19
16:06
Earnings
Herman Miller reports Q1 adjusted EPS 84c, consensus 78c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Oct

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.